Equities

Healthy Extracts Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HYEX:QBB

Healthy Extracts Inc

Actions
  • Price (USD)2.00
  • Today's Change0.00 / 0.00%
  • Shares traded980.00
  • 1 Year change--
  • Beta-1.0465
Data delayed at least 15 minutes, as of Feb 12 2026 19:23 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Healthy Extracts Inc. is a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals. The Company's subsidiaries, BergametNA and Ultimate Brain Nutrients, offer clinically tested heart and brain health formulations. BergametNA offers a heart health supplement distributed in North America containing Citrus Bergamot SuperFruit, a superfruit which has a concentration of polyphenols and flavonoids. It develops, manufactures and distributes bergamot-based products in tablet and capsule form under various brands, including BergaMet Pro+ and BergaMet SPORTSHEART. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF and Brain Activate - ENERGY Gel. It holds exclusive IP on delivery systems that include Gelteq gel-packs and the Gut Health Straw, both of which enable bioavailability and consumer convenience. It is also an advanced developer and manufacturer of precision-dosed nutraceutical gummies.

  • Revenue in USD (TTM)3.59m
  • Net income in USD-1.17m
  • Incorporated2014
  • Employees2.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HYEX:QBB since
announced
Transaction
value
Gummy USA LLCDeal completed19 Jul 202519 Jul 2025Deal completed11.11%23.54m
Data delayed at least 15 minutes, as of Feb 12 2026 19:23 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TherapeuticsMD Inc2.80m73.00k26.62m1.00368.590.9757.879.520.00620.02610.24192.370.0715--0.80022,796,000.000.1867-42.650.2169-112.14----2.61-193.47---5,240.000.00--35.25-48.7269.97------
Medicus Pharma Ltd-100.00bn-100.00bn27.63m-----------------0.0434-----------361.95----------------1.13-------109.90------
Kyntra Bio Inc8.30m-131.13m29.65m225.00------3.57-32.4953.342.05-4.210.0413-1.470.42136,880.00-64.00-39.47-260.98-61.33345.6990.21-1,548.18-199.023.60--0.5269---36.71-35.0752.60---45.94--
United-Guardian Inc10.06m1.96m29.91m24.0015.262.8314.492.970.42660.42662.192.300.79113.827.58419,180.4015.4126.9117.8531.1650.6054.1619.4826.976.16--0.0092.3411.91-2.1825.94-7.3530.65-8.64
SCYNEXIS Inc2.93m-25.30m31.89m28.00--0.8753--10.88-0.5107-0.51070.05930.86830.0391--0.5776104,714.30-33.71-20.51-43.65-24.9733.32---862.89-64.82----0.00---97.3398.68-131.75------
Hyperion DeFi Inc345.32k-26.40m32.11m13.00--0.3837--92.99-20.32-20.320.03859.880.0065--1.0626,563.08-48.31-102.28-59.47-168.53-798.1160.58-7,385.51-856.97----0.0976--1,412.93---82.75---0.6271--
Healthy Extracts Inc3.59m-1.17m33.74m2.00--1.40--9.40-0.3195-0.31950.90951.430.25051.42140.671,794,555.00-8.19-61.21-9.09-111.6052.3751.30-32.71-82.010.6491-2.840.0421--25.2432.9966.01------
BioXcel Therapeutics Inc752.00k-68.21m34.55m37.00------45.95-10.41-10.410.1023-4.450.0160.9718501.3320,324.32-145.62-76.45-449.90-88.28-28.19---9,070.61-14,760.231.16-3.255.40--64.20--66.71------
Celularity Inc40.58m-80.71m36.91m123.00------0.9097-3.34-3.341.69-0.71210.33396.145.24329,902.40-66.35-23.42-158.76-26.8350.61---198.75-294.700.123-6.572.01--138.11--70.51------
Talphera Inc28.00k-12.46m36.98m13.00--1.89--1,320.72-0.3808-0.3780.00090.42070.0011----2,153.85-48.15-14.86-54.44-19.40-----44,503.57-446.19----0.00---100.00---26.41------
Earth Science Tech Inc34.87m3.51m37.88m76.0011.156.629.781.090.01170.01170.11580.01965.0614.89148.30458,876.6050.5224.0476.21--73.8471.089.995.500.86065.650.0067--177.05128.98300.63------
Telomir Pharmaceuticals Inc0.00-11.25m39.54m----5.57-----0.3739-0.37390.000.20630.00-------266.47---303.19--------------0.00-------26.48------
RADNOSTIX, INC.14.07m-231.26k40.05m41.00--9.78237.962.85-0.0004-0.00040.02680.00780.81475.968.18343,260.30-1.341.32-1.681.9559.8959.45-1.641.951.06-0.29280.59540.0013.319.19100.99--28.22--
Rockwell Medical Inc75.58m-5.48m40.59m244.00--1.10--0.537-0.1583-0.15832.200.93951.3212.928.78309,741.80-9.63-32.92-12.15-46.6115.818.00-7.30-23.863.50-6.130.2141--21.3810.6194.31--11.47--
Zhengye Biotechnology Holding Ltd22.25m-2.80m43.60m277.00--1.01129.041.96-0.059-0.0590.47870.91310.30991.622.0480,341.63-4.60---7.79--37.37---14.83--1.10-7.000.1902---11.95---64.04------
Data as of Feb 12 2026. Currency figures normalised to Healthy Extracts Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.